Study Name:
LEARN: An Open-Label, Single-Arm Study in Moderate Asthma Participants Comparing the Treatment with Long-Acting Beta Agonist Between At-Home Mobile Spirometry and In-Clinic Spirometry
Targeted Disease(s):
Asthma
Purpose of Study:
To compare the treatment effect between at-home mobile spirometry and in-clinic spirometry in participants with moderate asthma, receiving a long-acting beta agonist (LABA) treatment.
Study Dates:
April 1, 2023 - December 1, 2023
Study Location:
Nationwide
Sponsors:
Koneksa Health
Contact:
Phone Number: 551-866-0025
Email: [email protected]
ClinicalTrails.gov Identifier:
NCT05757908